As evidenced from the clinical trial (mentioned above) involving melasma patients, improvements of up to 25% were recorded after 56 days, and up to over 50% after 84 days. Results from the clinical trial were measured using both Visia Skin Analysis and Mexameter by dermatologist investigators.